Beverly Hills, CA, United States of America

Alan M Fogelman

USPTO Granted Patents = 25 

 

 

Average Co-Inventor Count = 2.4

ph-index = 12

Forward Citations = 329(Granted Patents)


Location History:

  • Beverly Hills, CA (US) (2003 - 2013)
  • Los Angeles, CA (US) (2017 - 2021)

Company Filing History:


Years Active: 2003-2021

Loading Chart...
Loading Chart...
Loading Chart...
25 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Alan M. Fogelman

Introduction: Alan M. Fogelman is a prominent inventor located in Beverly Hills, California, recognized for his substantial contributions to the field of biochemistry and pharmacology. With an impressive portfolio that includes 25 patents, Fogelman has been at the forefront of innovations that aim to enhance health outcomes through genetic engineering and novel therapeutic approaches.

Latest Patents: Among Fogelman’s latest patents is the invention focused on "Ezetimibe-associated ApoA-I mimetic peptides showing enhanced synergism." This patent presents various embodiments of ezetimibe-associated apoA-I mimetic peptides that exhibit improved synergistic activity between ezetimibe and the apoA-I peptide in vivo. Specifically, it discusses the Ez-T6F peptide and methods for synthesizing these innovative peptides, which involve incubating ezetimibe with the apoA-I mimetic peptide in specific solutions and subsequently drying the mixture.

Another significant patent is concerned with "Modulating disease through genetic engineering of plants." This patent encompasses transgenic plants, such as transgenic tomatoes, designed to express peptides with biological activity that can lower serum amyloid A (SAA) levels, increase paroxonase activity, and improve the HDL inflammatory index when consumed by mammals.

Career Highlights: Alan M. Fogelman has held important positions in esteemed institutions, including the University of California and the UAB Research Foundation. His research has significantly advanced the understanding of lipoprotein functionality and its implications for cardiovascular health.

Collaborations: Fogelman has collaborated with notable scientists, including Mohamad Navab and Gattadahalli M. Anantharamaiah, with whom he has shared insights and expertise to enhance research efforts in the field of lipid biology and therapeutics.

Conclusion: Alan M. Fogelman’s innovative spirit and dedication have led to numerous impactful inventions, firmly establishing him as a vital contributor to biomedical research. His work not only pushes the boundaries of scientific understanding but also holds promise for practical applications in medicine and health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…